Search Results 801-810 of 17481 for problematic
This trial will consist of three arms: Part A, Part B, and Part C. Part A has two groups. The first group will enroll adult subjects with cystic fibrosis (CF) ...
Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...
The purpose of this study is to determine the recommended dose of tucatinib when combined with trastuzumab and modified FOLFOX7 (mFOLFOX7) or CAPOX in subjects ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Learn which medicines are more likely to cause an allergic reaction, what symptoms look like and what treatments can calm such a reaction.
Learn about the different types of neurological conditions that affect movement.
Julie Ferris-Tillman, Ph.D. February 11, 2026. Advancing epilepsy care: Mayo Clinic neurologist Dr. Gregory Worrell (VIDEO) featured image. Research.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.